{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:53:18Z","timestamp":1791399198800,"version":"4.3.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013317","name":"Lipedema Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100316","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:00:19Z","timestamp":1786690819000},"page":"100316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["GLP-1 and GLP-1\/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey"],"prefix":"10.1016","volume":"19","author":[{"given":"Ashok","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2067-2835","authenticated-orcid":false,"given":"Jonathan","family":"Kartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitie","family":"Daftuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Harmacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Samouhos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Galia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Mascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-4568","authenticated-orcid":false,"given":"Jesse C.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100316_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13953","article-title":"Lipedema: progress, challenges, and the road ahead","author":"Cifarelli","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2026.100316_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/aps.2011.153","article-title":"Rare adipose disorders (RADs) masquerading as obesity","volume":"33","author":"Herbst","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.obpill.2026.100316_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/life15091397","article-title":"New characterization of lipedema stages: focus on pain, water, fat and skeletal muscle","volume":"15","author":"Al-Ghadban","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.obpill.2026.100316_bib4","article-title":"Lipedema: a relatively common disease with extremely common misconceptions","volume":"4","author":"Buck","year":"2016","journal-title":"Plastic Reconstr Surg, Glob Open"},{"key":"10.1016\/j.obpill.2026.100316_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.obpill.2026.100316_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2026.100316_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.obpill.2026.100316_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.obpill.2026.100316_bib9","unstructured":"HealthMeasures' PROMIS global health scoring manual, v1.2 n.d."},{"key":"10.1016\/j.obpill.2026.100316_bib10","first-page":"33","article-title":"Liposuction is an effective treatment for lipedema\u2013results of a study with 25 patients","volume":"9","author":"Rapprich","year":"2011","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"10.1016\/j.obpill.2026.100316_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/02683555211015887","article-title":"Standard of care for lipedema in the United States","volume":"36","author":"Herbst","year":"2021","journal-title":"Phlebol J Venous Dis"},{"key":"10.1016\/j.obpill.2026.100316_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/ph18050668","article-title":"The efficacy and safety of tirzepatide in patients with diabetes and\/or obesity: systematic review and meta-analysis of randomized clinical trials","volume":"18","author":"Liu","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.obpill.2026.100316_bib13","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s11136-021-02925-y","article-title":"Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures","volume":"30","author":"Terwee","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.obpill.2026.100316_bib14","doi-asserted-by":"crossref","DOI":"10.1590\/1677-5449.202400252","article-title":"Lipedema: exploring pathophysiology and treatment strategies \u2013 state of the art","volume":"23","author":"Kamamoto","year":"2024","journal-title":"J Vasc Bras"},{"key":"10.1016\/j.obpill.2026.100316_bib15","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.obpill.2026.100316_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1532076","article-title":"The role of GIPR in food intake control","volume":"16","author":"James-Okoro","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.obpill.2026.100316_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41387-025-00382-x","article-title":"Food noise: definition, measurement, and future research directions","volume":"15","author":"Dhurandhar","year":"2025","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.obpill.2026.100316_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13679-025-00642-y","article-title":"Therapeutic applications of ketogenic diets in lipedema: a narrative review of current evidence","volume":"14","author":"Sanlier","year":"2025","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.obpill.2026.100316_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/endocrines6020024","article-title":"Lipedema: from women's hormonal changes to nutritional intervention","volume":"6","author":"Tomada","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.obpill.2026.100316_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/db24-0890","article-title":"Adipose tissue biology and effect of weight loss in women with lipedema","volume":"74","author":"Cifarelli","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.obpill.2026.100316_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108743","article-title":"Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: a systematic review and meta-analysis of randomized control trials","volume":"38","author":"Xie","year":"2024","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.obpill.2026.100316_bib22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.obpill.2026.100316_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.obpill.2026.100316_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4093\/dmj.2023.0277","article-title":"Glucagon-like Peptide-1: new regulator in lipid metabolism","volume":"48","author":"Bu","year":"2024","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.obpill.2026.100316_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pcd.2025.03.008","article-title":"The promise of tirzepatide: a narrative review of metabolic benefits","volume":"19","author":"Sokary","year":"2025","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.obpill.2026.100316_bib26","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.obpill.2026.100316_bib27","article-title":"Metformin and tirzepatide in lipedema: targeting fibrosis and inflammation through complementary pathways","author":"Lima","year":"2026","journal-title":"A Mechanistic, Translational and Therapeutic Perspective"},{"key":"10.1016\/j.obpill.2026.100316_bib28","first-page":"34121","article-title":"Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes: a role for protein kinase B, LKB1, and AMP-activated protein kinase cascade","volume":"285","author":"Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.obpill.2026.100316_bib29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/oby.2006.129","article-title":"Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification","volume":"14","author":"Getty-Kaushik","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2026.100316_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.9734\/jpri\/2025\/v37i37664","article-title":"Metabolic therapy for lipedema: can tirzepatide overcome the treatment gap?","volume":"37","author":"Viana","year":"2025","journal-title":"J Pharm Res Int"},{"key":"10.1016\/j.obpill.2026.100316_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/clinpract15070128","article-title":"A case series on the efficacy of the pharmacological treatment of lipedema: the Italian experience with exenatide","volume":"15","author":"Patton","year":"2025","journal-title":"Clin Pract"},{"key":"10.1016\/j.obpill.2026.100316_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/life14111346","article-title":"Evaluation of the effectiveness of compression therapy combined with exercises versus exercises only among lipedema patients using various outcome measures","volume":"14","author":"Czerwi\u0144ska","year":"2024","journal-title":"Life"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:29:59Z","timestamp":1787988599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S2667368126000720"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100316","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 and GLP-1\/GIP receptor agonist medication use and self-reported outcomes in individuals with lipedema: Results from a large online survey","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100316"}}